ea0073aep480 | Pituitary and Neuroendocrinology | ECE2021
Caklili Ozge Telci
, Ayşe Merve Çelik
, Istemihan Zulal
, Selcukbiricik Ozlem Soyluk
, Yarman Sema
ObjectivesMale prolactinoma patients mostly have hypogonadotropic symptoms. While treatment with dopamine agonists (DAs; such as bromocriptine or cabergoline) leads to recovery of sexual glands, it can lead to impulsive control disorders as an undesirable side effect. The aim of this retrospective study is to determine the level of testosterone that eliminates symptoms, provides fertility and does not cause this undesirable side effect regardless of prol...